Skip to main content

Table 3 Antibiotic usage and clinical outcomes in patients with CRAB pneumonia. Clinical outcomes of different antibiotic regimens in CRAB pneumonia

From: Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia

Antibiotics

Number of cases

Number of deaths(Deaths/Total*100%)

Sulbactam + Carbapenems + Tigecycline

59

12(20.34%)

Sulbactam + Carbapenems

24

3(1.25%)

Sulbactam + Tigecycline

30

2(6%)

Carbapenems + Tigecycline

23

3(13.04%)

Sulbactam

0

0(-)

Carbapenems*

21

21(100%)

Colistin

2

1(50%)

Not using any of the above three drugs

0

0(-)

  1. * These patients were treated with other types of antibiotics, including 12 cases with quinolones, 7 cases with other β-lactams, and 2 cases with tetracyclines